The award recipient has shown outstanding performance in the generic drugs sector, in terms of revenue and market share among its competitors. With an on-going commitment to bring more affordable drugs to a wider population, this company continues to broaden its product portfolio and expand its presence to more countries within the region.

Frost & Sullivan congratulates CCM Pharma